花粉症の世界市場レポート 2025年

花粉症市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.1％で、102億6,000万米ドルに成長します。予測期間中に予想される成長は、アレルギー疾患の有病率の上昇、汚染レベルの上昇、気候変動の進行による影響、アレルギー治療に対する意識の高まり、治療オプションの利用可能性の拡大、ヘルスケアへのアクセスの改善、予防対策と環境衛生への関心の高まりなど、いくつかの要因に起因しています。この期間の主な動向としては、より効果的な免疫療法治療法の開発、個別化されたアレルギー治療薬の採用、花粉をブロックする鼻フィルターの革新、HEPAフィルターを備えた空気清浄機の進歩、点鼻スプレー製剤の改良、天然有機アレルギー緩和製品の人気の高まり、アレルゲン曝露をリアルタイムでモニターするウェアラブル機器の進歩などが挙げられます。

アレルギー性鼻炎の有病率の増加は、花粉アレルゲン市場の成長を促進すると予想されます。アレルギー性鼻炎は、鼻に炎症を起こし、くしゃみ、鼻づまり、目のかゆみなどの症状を引き起こす疾患で、多くの場合、花粉やほこりによって引き起こされます。アレルギー性鼻炎の増加は、環境汚染、気候変動、都市化、ライフスタイルの変化など、アレルゲンや汚染物質にさらされる機会が増える要因と関連しています。この症状は一般的に花粉症によって引き起こされ、花粉との接触によって鼻腔に炎症が起こる。例えば、2023年10月、米国を拠点とするアレルギー臨床研究に特化した組織である世界アレルギー機構は、アレルギー性鼻炎は全世界で4億人以上が罹患しており、有病率は成人で10％から30％、小児では40％を超えると報告しています。その結果、アレルギー性鼻炎の有病率の増加が花粉アレルゲン市場の拡大を牽引しています。

花粉症市場の主要企業は、アレルギーの診断、治療、管理のための統合ソリューションを提供し、患者の予後改善と利便性を確保する包括的なアレルギー治療プラットフォームの構築に注力しています。花粉症の包括的なアレルギーケアプラットフォームとは、花粉症患者を最初から最後までサポートするために設計された包括的なシステムやサービスのことです。例えば、2023年2月、インドの製薬会社ネクター・ライフ・サイエンス社は、包括的なアレルギー・ケア・プラットフォームであるネクターを立ち上げ、最初の製品として個別化された舌下免疫療法用ドロップを発売しました。ネクターのアレルギー用ドロップは、CLIA認定の家庭用アレルギー検査に基づき、アレルギーの根本原因をターゲットにカスタム処方されています。注射や抗ヒスタミン薬といった従来の治療に代わる、便利で効果的な治療法です。このプログラムでは、3ヵ月ごとの宅配と継続的な処方により治療プロセスを簡素化し、中等度から重度のアレルギー患者が長期的な耐性を築き、症状を軽減できるよう支援します。この革新的なアプローチは、個別化、利便性、実証された効果を組み合わせることで、アレルギー治療を変革することを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界花粉症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の花粉症市場：成長率分析
• 世界の花粉症市場の実績：規模と成長, 2019-2024
• 世界の花粉症市場の予測：規模と成長, 2024-2029, 2034F
• 世界花粉症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の花粉症市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 消耗品
• サービス
• 世界の花粉症市場アレルゲンの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 食品
• 吸入
• 薬
• その他のアレルゲンの種類
• 世界の花粉症市場治療薬クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• 鼻づまり解消薬
• コルチコステロイド
• 肥満細胞安定剤
• ロイコトリエン阻害剤
• 鼻腔抗コリン薬
• 免疫調節薬
• 自己注射用エピネフリン
• 免疫療法
• 世界の花粉症市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断検査室
• 病院
• 世界の花粉症市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アレルギー検査機器
• 診断装置
• 監視デバイス
• 世界の花粉症市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アレルギー検査キット
• 花粉フィルター
• 診断試薬
• 治療薬（抗ヒスタミン薬）
• 世界の花粉症市場、サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アレルギー検査サービス
• 免疫療法サービス
• 相談・診断サービス

第7章 地域別・国別分析

• 世界の花粉症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の花粉症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 花粉症市場：競合情勢
• 花粉症市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi SA
• AstraZeneca Plc
• Novartis AG
• GlaxoSmithKline PLC
• Astellas Pharma Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd
• Genentech Inc.
• Omega Pharma
• ALK Abello
• Stallergenes Greer
• Aimmune Therapeutics
• Allergy Therapeutics
• McNeil Consumer Healthcare
• Meda Pharmaceuticals Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 花粉症市場2029：新たな機会を提供する国
• 花粉症市場2029：新たな機会を提供するセグメント
• 花粉症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pollen allergy is an immune system response to pollen from trees, grasses, and weeds. It occurs when the immune system mistakenly identifies pollen as harmful, triggering the release of chemicals such as histamine. Pollen allergies are typically seasonal, with symptoms peaking in spring, summer, or fall, depending on the type of pollen an individual is allergic to.

The pollen allergy market includes key product categories such as instruments, consumables, and services. Instruments are medical devices used for diagnosing, monitoring, and treating pollen allergies. Examples include nasal irrigation devices, allergy testing equipment, and inhalers. Allergens are classified into food, inhaled, drug, and other types. Treatments for pollen allergies encompass antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto-injectable epinephrine, and immunotherapy. These products are mainly used in diagnostic laboratories and hospitals.

The pollen allergy market research report is one of a series of new reports from The Business Research Company that provides pollen allergy market statistics, including the pollen allergy industry's global market size, regional shares, competitors with a pollen allergy market share, detailed pollen allergy market segments, market trends and opportunities, and any further data you may need to thrive in the pollen allergy industry. This pollen allergy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pollen allergy market size has grown strongly in recent years. It will grow from $6.92 billion in 2024 to $7.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the historic period can be attributed to several factors, including increased awareness of allergic conditions, higher investments in healthcare infrastructure, the impact of climate change resulting in longer pollen seasons, and the rise in urbanization, which has led to greater exposure to allergens.

The pollen allergy market size is expected to see strong growth in the next few years. It will grow to $10.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth anticipated during the forecast period can be attributed to several factors, including the rising prevalence of allergic conditions, increasing pollution levels, the ongoing effects of climate change, greater awareness of allergy treatments, the expanding availability of treatment options, improved healthcare access, and a heightened focus on preventive measures and environmental health. Key trends during this period include the development of more effective immunotherapy treatments, the adoption of personalized allergy medications, innovations in pollen-blocking nasal filters, advancements in air purifiers equipped with HEPA filters, improvements in nasal spray formulations, the growing popularity of natural and organic allergy relief products, and the advancement of wearable devices that monitor allergen exposure in real-time.

The increasing prevalence of allergic rhinitis is expected to drive the growth of the pollen allergen market. Allergic rhinitis is a condition that causes inflammation in the nose, leading to symptoms such as sneezing, nasal congestion, and itchy eyes, often triggered by pollen or dust. The rise in allergic rhinitis is linked to factors such as environmental pollution, climate change, urbanization, and lifestyle changes, which increase exposure to allergens and pollutants. This condition is commonly caused by pollen allergies, where contact with pollen leads to inflammation in the nasal passages. For example, in October 2023, the World Allergy Organization, a US-based organization focused on clinical allergic studies, reported that allergic rhinitis affects more than 400 million people worldwide, with prevalence rates ranging from 10% to 30% in adults and surpassing 40% in children. As a result, the growing prevalence of allergic rhinitis is driving the expansion of the pollen allergen market.

Leading companies in the pollen allergy market are focusing on creating comprehensive allergy care platforms that offer integrated solutions for the diagnosis, treatment, and management of allergies, ensuring better patient outcomes and convenience. A comprehensive allergy care platform for pollen allergy is an all-encompassing system or service designed to support individuals with pollen allergies from start to finish. For example, in February 2023, Nectar Life Sciences, a pharmaceutical company based in India, launched Nectar, a comprehensive allergy care platform, and introduced personalized sublingual immunotherapy drops as its first product. These custom-formulated Nectar allergy drops are based on a CLIA-certified at-home allergy test and target the root cause of allergies. They provide a convenient and effective alternative to traditional treatments such as shots and antihistamines. The program simplifies the treatment process with home delivery and ongoing prescriptions every three months, helping patients with moderate to severe allergies build long-term tolerance and reduce symptoms. This innovative approach aims to transform allergy care by combining personalization, convenience, and proven effectiveness.

In September 2023, Stallergenes Greer International AG, a pharmaceutical company based in Switzerland, acquired the peanut allergy oral immunotherapy treatment Palforzia from Nestle S.A. for an undisclosed sum. This acquisition enhances Stallergenes' position as a leader in allergen immunotherapy by broadening its portfolio to include both respiratory and food allergy treatments. Nestle S.A., a Swiss food and beverage company, is actively involved in addressing a range of allergies, including food and environmental allergies such as those related to pollen.

Major players in the pollen allergy market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd, Genentech Inc., Omega Pharma, ALK Abello, Stallergenes Greer, Aimmune Therapeutics, Allergy Therapeutics, McNeil Consumer Healthcare, Meda Pharmaceuticals Inc, HAL Allergy Group, Allergopharma, Biomay AG, Leti Pharma, Epigenomics AG, Alerpharma S.A

North America was the largest region in the pollen allergy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pollen allergy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pollen allergy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pollen allergy market consists of sales of nasal sprays, eye drops, allergy masks, air purifiers, and pollen blockers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pollen Allergy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pollen allergy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pollen allergy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pollen allergy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Consumables; Services
• 2) By Allergen Type: Food; Inhaled; Drug; Other Allergen Types
• 3) By Therapeutics Drug class: Antihistamines; Decongestants; Corticosteroids; Mast Cell Stabilizers; Leukotriene Inhibitors; Nasal Anticholinergics; Immunomodulators; Auto injectable Epinephrine; Immunotherapy
• 4) By End-User: Diagnostic Laboratories; Hospitals
• Subsegments:
• 1) By Instruments: Allergy Testing Equipment; Diagnostic Devices; Monitoring Devices
• 2) By Consumables: Allergy Test Kits; Pollen Filters; Diagnostic Reagents; Treatment Medications (Antihistamines)
• 3) By Services: Allergy Testing Services; Immunotherapy Services; Consultation And Diagnostic Services
• Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck KGaA; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pollen Allergy Market Characteristics

3. Pollen Allergy Market Trends And Strategies

4. Pollen Allergy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pollen Allergy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pollen Allergy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pollen Allergy Market Growth Rate Analysis
• 5.4. Global Pollen Allergy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pollen Allergy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pollen Allergy Total Addressable Market (TAM)

6. Pollen Allergy Market Segmentation

• 6.1. Global Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Consumables
• Services
• 6.2. Global Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Food
• Inhaled
• Drug
• Other Allergen Types
• 6.3. Global Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anticholinergics
• Immunomodulators
• Auto Injectable Epinephrine
• Immunotherapy
• 6.4. Global Pollen Allergy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Laboratories
• Hospitals
• 6.5. Global Pollen Allergy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergy Testing Equipment
• Diagnostic Devices
• Monitoring Devices
• 6.6. Global Pollen Allergy Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergy Test Kits
• Pollen Filters
• Diagnostic Reagents
• Treatment Medications (Antihistamines)
• 6.7. Global Pollen Allergy Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergy Testing Services
• Immunotherapy Services
• Consultation And Diagnostic Services

7. Pollen Allergy Market Regional And Country Analysis

• 7.1. Global Pollen Allergy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pollen Allergy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pollen Allergy Market

• 8.1. Asia-Pacific Pollen Allergy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pollen Allergy Market

• 9.1. China Pollen Allergy Market Overview
• 9.2. China Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pollen Allergy Market

• 10.1. India Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pollen Allergy Market

• 11.1. Japan Pollen Allergy Market Overview
• 11.2. Japan Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pollen Allergy Market

• 12.1. Australia Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pollen Allergy Market

• 13.1. Indonesia Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pollen Allergy Market

• 14.1. South Korea Pollen Allergy Market Overview
• 14.2. South Korea Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pollen Allergy Market

• 15.1. Western Europe Pollen Allergy Market Overview
• 15.2. Western Europe Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pollen Allergy Market

• 16.1. UK Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pollen Allergy Market

• 17.1. Germany Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pollen Allergy Market

• 18.1. France Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pollen Allergy Market

• 19.1. Italy Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pollen Allergy Market

• 20.1. Spain Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pollen Allergy Market

• 21.1. Eastern Europe Pollen Allergy Market Overview
• 21.2. Eastern Europe Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pollen Allergy Market

• 22.1. Russia Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pollen Allergy Market

• 23.1. North America Pollen Allergy Market Overview
• 23.2. North America Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pollen Allergy Market

• 24.1. USA Pollen Allergy Market Overview
• 24.2. USA Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pollen Allergy Market

• 25.1. Canada Pollen Allergy Market Overview
• 25.2. Canada Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pollen Allergy Market

• 26.1. South America Pollen Allergy Market Overview
• 26.2. South America Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pollen Allergy Market

• 27.1. Brazil Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pollen Allergy Market

• 28.1. Middle East Pollen Allergy Market Overview
• 28.2. Middle East Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pollen Allergy Market

• 29.1. Africa Pollen Allergy Market Overview
• 29.2. Africa Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pollen Allergy Market Competitive Landscape And Company Profiles

• 30.1. Pollen Allergy Market Competitive Landscape
• 30.2. Pollen Allergy Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Pollen Allergy Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. AstraZeneca Plc
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline PLC
• 31.5. Astellas Pharma Inc.
• 31.6. Bausch Health Companies Inc.
• 31.7. Sun Pharmaceutical Industries Ltd
• 31.8. Genentech Inc.
• 31.9. Omega Pharma
• 31.10. ALK Abello
• 31.11. Stallergenes Greer
• 31.12. Aimmune Therapeutics
• 31.13. Allergy Therapeutics
• 31.14. McNeil Consumer Healthcare
• 31.15. Meda Pharmaceuticals Inc

32. Global Pollen Allergy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pollen Allergy Market

34. Recent Developments In The Pollen Allergy Market

35. Pollen Allergy Market High Potential Countries, Segments and Strategies

• 35.1 Pollen Allergy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pollen Allergy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pollen Allergy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer